Could real-world evidence help shape the future of drug development?

Could real-world evidence help shape the future of drug development?

STAT Plus: Could real-world evidence help shape the future of drug development?

By REBECCA ROBBINS AND ADAM FEUERSTEIN AND DAMIAN GARDE

AETION

STAT speaks with Carolyn Magill, the CEO of Aetion and one of the best-known executives in the space known as real-world evidence.

READ MORE